In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OTR acting director

Executive Summary

FDA Office of Testing & Research Division of Pharmaceutical Analysis Director Cindy Buhse succeeds Ajaz Hussain as OTR acting director effective Oct. 31. Buhse has worked at the agency since 2001. Hussain, who also served as deputy director of the Office of Pharmaceutical Science, left FDA Oct. 28 to become VP-biopharmaceutical development at Sandoz (1"The Pink Sheet" Oct. 10, 2005, p. 3)...

You may also be interested in...



New OTR director

FDA appoints Vincent Vilker as director of the Office of Testing and Research, within the Office of Pharmaceutical Science. Vilker replaces Ajaz Hussain, who left FDA in October to become VP-biopharmaceutical development at Sandoz (1"The Pink Sheet" Oct. 31, 2005, In Brief). Vilker hails from the National Institute of Standards where he served as chief of the biotechnology division...

FDA Implementing New CMC Review Process Through Revamped Office

FDA is changing its review of chemistry, manufacturing and controls submissions with a new quality assessment office that will involve greater staff specialization

Brazil Levels Medtech ICT Tariffs Playing Field

All medtech in Brazil will soon be subject to standardized industrial tariffs and development-related fiscal incentives, following a reform of rules relating to ICT across all industries.

Topics

UsernamePublicRestriction

Register

PS046493

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel